Wirkstoffe & Arzneimittelsicherheit

Nebenwirkungen · CellCept

CellCept 500 mg powder for concentrate for solution for infusion · Abschnitt 4.8 · PDF-Seite 34

HOS-085290 · Präparat HOS-083095

(MedDRA) Renal Hepatic transplant transplant System Organ Class Hyperuricaemia Common Common Gout Common Common Weight decreased Common Common Psychiatric disorders Confusional state Common Very Common Depression Common Very Common Insomnia Common Very Common Agitation Uncommon Common Anxiety Common Very Common Thinking abnormal Uncommon Common Nervous system disorders Dizziness Common Very Common Headache Very Common Very Common Hypertonia Common Common Paresthesia Common Very Common Somnolence Common Common Tremor Common Very Common Convulsion Common Common Dysgeusia Uncommon Uncommon Cardiac disorders Tachycardia Common Very Common Vascular disorders Hypertension Very Common Very Common Hypotension Common Very Common Lymphocele Uncommon Uncommon Venous thrombosis Common Common Vasodilatation Common Common Respiratory, thoracic and mediastinal disorders Bronchiectasis Uncommon Uncommon Cough Very Common Very Common Dyspnoea Very Common Very Common Interstitial lung disease Uncommon Very Rare Pleural effusion Common Very Common Pulmonary fibrosis Very Rare Uncommon Gastrointestinal disorders Abdominal distension Common Very Common Abdominal pain Very Common Very Common Colitis Common Common Constipation Very Common Very Common Decreased appetite Common Very Common Diarrhoea Very Common Very Common Dyspepsia Very Common Very Common

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.